Datavault AI (NASDAQ: DVLT) Forms DelivMeds AI Venture Through Wellgistics Partnership and Strategic Acquisitions

Datavault AI (NASDAQ: DVLT) announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a healthcare platform combining AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification and direct-to-consumer healthcare delivery through three concurrent transactions, including an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property and a controlling stake in Tollo Health. The combined transactions carry an expected approximate asset […]

announced a binding term sheet with to create DelivMeds AI, a healthcare platform combining AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification and direct-to-consumer healthcare delivery through three concurrent transactions, including an expanded PharmacyChain(TM) license, acquisition of QOLPOM intellectual property and a controlling stake in Tollo Health. The combined transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions.

To view the full press release, visit https://ibn.fm/yIVh9

About Datavault AI

Datavault AI(TM) is leading the way in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Science divisions.

At a glance

Company: Datavault AI
Ticker: NASDAQ: DVLT
Announcement: Partnership
Location: Philadelphia, PA

Key figures

Expected approximate asset value of combined transactions: $4 billion

Products and programs

DelivMeds AI
PharmacyChain
QOLPOM intellectual property
Tollo Health

The Acoustic Sciences division features WiSA(R), ADIO(R), and Sumerian(R) patented technologies and industry-first foundational spatial and multichannel wireless, high-definition sound transmission technologies with intellectual property covering audio timing, synchronization, and multi-channel interference cancellation. The Data Science division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization. The platform serves multiple industries, including high-performance computing software licensing for sports & entertainment, biotech, fintech, real estate, healthcare, energy, and more.

The Information Data Exchange(R) enables Digital Twins and the licensing of name, image, and likeness by securely anchoring to immutable metadata, fostering responsible AI with integrity. The Company’s technology suite offers AI- and machine-learning-based automation, third-party integration, and detailed analytics. Datavault AI is headquartered in Philadelphia, PA. Learn more at .

NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

The latest news and updates relating to DVLT are available in the company’s newsroom at https://ibn.fm/DVLT

Corporate Communications

IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]

In brief

Datavault AI says it has signed a binding term sheet with Wellgistics to establish DelivMeds AI, a healthcare venture combining pharmacy services, artificial intelligence, blockchain-based agreements and biometric identity checks. The proposed arrangement also includes consumer-facing healthcare delivery. The company describes three transactions: an expanded license for PharmacyChain, the purchase of QOLPOM intellectual property and a controlling investment in Tollo Health. The transactions are expected to represent approximately $4 billion in asset value, subject to an independent fairness opinion. Datavault AI says the effort is designed to enable a nationwide expansion of data-based care delivery and patient engagement offerings. The release does not provide further details about the term sheet or transaction timing.

Key takeaways

Datavault AI and Wellgistics signed a binding term sheet to form the DelivMeds AI venture.
The plan involves an expanded PharmacyChain license, QOLPOM intellectual property and a controlling stake in Tollo Health.
The combined transactions are expected to have approximately $4 billion in asset value, subject to an independent fairness opinion.
The company says the venture is intended to support national expansion of healthcare delivery and patient engagement solutions.

SEC filings

Earlier from Datavault AI

Back to News Center